全文获取类型
收费全文 | 1886230篇 |
免费 | 122975篇 |
国内免费 | 17217篇 |
专业分类
耳鼻咽喉 | 19796篇 |
儿科学 | 52488篇 |
妇产科学 | 53826篇 |
基础医学 | 232648篇 |
口腔科学 | 38094篇 |
临床医学 | 201812篇 |
内科学 | 430875篇 |
皮肤病学 | 41395篇 |
神经病学 | 148868篇 |
特种医学 | 80024篇 |
外国民族医学 | 74篇 |
外科学 | 275391篇 |
综合类 | 63926篇 |
现状与发展 | 106篇 |
一般理论 | 617篇 |
预防医学 | 106358篇 |
眼科学 | 33452篇 |
药学 | 104903篇 |
513篇 | |
中国医学 | 18095篇 |
肿瘤学 | 123161篇 |
出版年
2023年 | 37289篇 |
2022年 | 57896篇 |
2021年 | 71102篇 |
2020年 | 66279篇 |
2019年 | 47752篇 |
2018年 | 59885篇 |
2017年 | 55326篇 |
2016年 | 55107篇 |
2015年 | 59742篇 |
2014年 | 103485篇 |
2013年 | 98258篇 |
2012年 | 96443篇 |
2011年 | 96889篇 |
2010年 | 79456篇 |
2009年 | 72407篇 |
2008年 | 74485篇 |
2007年 | 77257篇 |
2006年 | 71501篇 |
2005年 | 66161篇 |
2004年 | 60613篇 |
2003年 | 58044篇 |
2002年 | 56203篇 |
2001年 | 53647篇 |
2000年 | 51949篇 |
1999年 | 47556篇 |
1998年 | 19660篇 |
1997年 | 16174篇 |
1996年 | 16135篇 |
1995年 | 14339篇 |
1994年 | 12047篇 |
1993年 | 10399篇 |
1992年 | 35658篇 |
1991年 | 34022篇 |
1990年 | 33282篇 |
1989年 | 28663篇 |
1988年 | 27304篇 |
1987年 | 14260篇 |
1986年 | 5901篇 |
1985年 | 7140篇 |
1984年 | 7898篇 |
1983年 | 6526篇 |
1982年 | 6552篇 |
1981年 | 6009篇 |
1980年 | 5582篇 |
1979年 | 4803篇 |
1978年 | 4601篇 |
1977年 | 3840篇 |
1976年 | 3489篇 |
1974年 | 3190篇 |
1973年 | 3013篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
目的 探讨桦木酸对大鼠肺纤维化模型肺组织中NF-κB、β-arrestin2表达的影响。方法 15只SPF级雄性SD大鼠分为对照组、模型组、桦木酸组,每组5只。对照组予以单次气管内注射1 mL·kg-1 0.9%生理盐水,模型组和桦木酸组予单次气管内快速注射5 mg·kg-1博来霉素建立大鼠肺纤维化模型。造模1天后,对照组及模型组给予10 mL·kg-1 1%可溶性淀粉溶液,桦木酸组给予50 mg·kg-1的桦木酸悬浮液,持续21天。HE、Masson染色方法观察肺组织病理改变。酶联免疫吸附法(ELISA)检测肺组织匀浆IL-6的水平。免疫组化法检测肺组织中NF-κB、β-arrestin2、IκBα的表达。结果 与对照组相比,模型组肺组织匀浆中IL-6水平升高,NF-κB、β-arrestin2、IκBα蛋白表达均上调(P<0.05)。与模型组相比,桦木酸组肺组织匀浆中IL-6水平降低,肺组织中NF-κB、β-arrestin2、IκBα蛋白表达均下调(P<0.05)。结论 桦木酸可减轻肺部炎症、减慢肺纤维化的发生发展,可能与下调肺组织中NF-κB、β-arrestin2有关。 相似文献
4.
5.
6.
《Clinical genitourinary cancer》2022,20(5):423-430
IntroductionDeferred treatment is a growing management strategy for low-risk prostate cancer. However, it is unknown whether this growth is mediated by patient factors. In this study, we sought to evaluate factors associated with deferred treatment in patients with low-risk prostate cancer and shifts in these factors after recent incorporation of active surveillance into national guidelines.Materials and MethodsWe identified 137,915 men diagnosed with low-risk prostate cancer (prostate-specific antigen <10 ng/mL, Gleason score ≤6, stage cT1-cT2a) in the National Cancer Database from 2010 to 2017. Multivariate logistic regression models were used to determine factors associated with deferred treatment. Interaction variables were added to determine whether trends in use of deferred treatment over time depend on race, income, education, and insurance status.ResultsThe use of deferred treatment among men with low-risk prostate cancer increased from 14.7% in 2010-2011 to 46.3% in 2016-2017 (P < .001). On multivariate analysis, deferred treatment was associated with older age, more contemporary year of diagnosis, black race, lower income, higher educational attainment, government insurance, being uninsured, treatment at an academic/research facility, and treatment at a facility in New England (each P < .05). Incorporation of interaction variables showed that black race, belonging to the two lowest income quartiles, government insurance, and being uninsured became less associated with deferred treatment in recent years.ConclusionsThe use of deferred treatment among men with low-risk prostate cancer increased significantly from 2010 to 2017. However, patients who were black, low-income, and not privately insured experienced smaller increases in deferred treatment. Interventions to increase uptake in these groups present opportunities to improve quality of care. 相似文献
7.
8.
9.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
10.